#Pharmaceuticals Market Size

[delvens-blog]

The global market for Pharmaceutical Packaging is expected to reach $122.6 billion by 2030 from $109.4 billion in 2022, registering impressive expansion at a compound annual growth rate (CAGR) of 6.7%. Some of the major players are Amcor Ltd., Becton, Dickinson, Aptargroup, Inc., Capsugel Inc., Gerresheimer AG, Schott AG, Terumo Corporation, WEST Pharmaceutical Services, Inc., Berry Plastics Group, Inc., Westrock Company, SGD SA, Comar LLC, International Paper Company, Owens Illinois Inc., Aptar Group Inc.

[rkingresearch]

Pharmaceutical Packaging Market Size, Value, Report 2022-2028

The Global Pharmaceutical Packaging Market Size was valued at USD 90.2 billion in 2021. The market is projected to grow by USD 144.2 billion in 2028, at a CAGR of 8.9%.

The global Pharmaceutical Packaging market research gives a detailed and practical analysis of the products and services in this market which provides a competitive advantage to the existing and new businesses. In depth study and overview of the market has been collected by the overall insight of the industry and specifies the market segmentation, potential opportunities, growing market trends and events, current and future advancements, and other elements. This report will also showcase many possibilities of upscaling the global Pharmaceutical Packaging market share size.

Get a Sample PDF of Report - https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/pharmaceutical-packaging-market/21601

The competitive landscape of Pharmaceutical Packaging market includes major players such as:

 The report includes all key points related to the most important determinants of Pharmaceutical Packaging industry’s growth. This research looks closely at the market competition, product development trends, and sale prospects such as evolutions of consumer behavior, current market need, client preferences, and changing needs and demand. Furthermore, the report discusses its prominent players, along with their new entrants, influential players and much more.

The Pharmaceutical Packaging market analysis will help companies identify potential development areas and create strategies to take advantage of emerging opportunities. It analyzes the current competitive environment in addition to offering key details like market statistics and product releases from leading companies in this industry. This industry is characterized in terms of market size, market coverage, market exchange rate, segmentation, and market share.

Inquire Before Buying This Research Report: https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/pharmaceutical-packaging-market/21601

The Pharmaceutical Packaging market is segmented by types into:

SEGMENTATION:-

 By Material

  By Product Type

 By Drug Delivery

 By Packaging Type

By Region

 Detailed analysis of applications and customers that use the services provided by the Pharmaceutical Packaging market is also discussed in the report. Similarly, it provides information about its key competitors and their footprints according to the respective regions. Along with it, the study will cover company portfolios, Pharmaceutical Packaging market growth opportunities, obstacles, collaborations, mergers and acquisitions.

Moreover, it provides a quick summary of the Pharmaceutical Packaging global market developments for the estimated period of time which will ultimately provide ideas to businesses in terms of working and processes of the Pharmaceutical Packaging market. This research has been generated based on the historical data and future possibilities of the market. The overall industry scale of the market has been studied from the global perspective by utilizing multiple research methodologies such as Porter’s five forces model, SWOT and PESTEL analysis.

Detailed TOC of Global Pharmaceutical Packaging Market @ https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/pharmaceutical-packaging-market/21601

TABLE OF CONTENTS:-

1. Executive Summary

2. Research Methodology

3. Market Outlook

4. COVID-19 Impact On Pharmaceutical Packaging Market

5. Global Pharmaceutical Packaging Market Overview, By Material, 2015 - 2028(USD Million)

6. Global Pharmaceutical Packaging Market Overview, By Product Type, 2015 - 2028(USD Million)

7. Global Pharmaceutical Packaging Market Overview, By Drug Delivery, 2015 - 2028(USD Million)

8. Global Pharmaceutical Packaging Market Overview, By Packaging Type, 2015 - 2028(USD Million)

9. Global Pharmaceutical Packaging Market Overview, By Geography, 2015 - 2028(USD Million)

10. North America Pharmaceutical Packaging Market Overview, By Countries, 2015 - 2028(USD Million)

About Us

Extrapolate is a global market research and content services firm that works closely with clients in various industries to improve market position, increase returns on marketing investments, and define and implement strategies that get real results.

In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets-not merely respond to them. Extrapolate helps clients develop market perspectives that drive commercial success.

Contact Us:

Extrapolate Phone: (+1) 888 328 2189 E-mail: talk@extrapolate.com Website: https://www.extrapolate.com

[mj2994-me-blog]

Pharmaceutical Contract Research Organization Market Market

Pharmaceutical Contract Research Organization Market Share Insights

Reed Intelligence has recently published a new report titled ""Global Pharmaceutical Contract Research Organization Market."" This comprehensive report delves into crucial aspects of the Bluetooth fingerprint scanner industry, offering valuable insights for both established and new market participants. It covers key factors such as market share, profitability, production, sales, manufacturing processes, advertising strategies, technological innovations, major industry players, and regional market breakdowns, among other important details.

Get Free Sample Report PDF @ https://reedintelligence.com/market-analysis/global-pharmaceutical-contract-research-organization-market/request-sample 

Pharmaceutical Contract Research Organization Market Share by Key Players

IQVIA

Syneos Health

Quintiles

PPD

Parexel

ICON

PRA Health Sciences

InVentiv

INC Research Holdings

CRL

Wuxi AppTec

Charles River

Envigo

Medpace Holdings

SGS

PSI CRO

Axcent Advanced Analytics

BIO Agile Therapeutics

Firma Clinical Research

Acculab Lifesciences

Azelix

CTSERV

PEPGRA

The report also covers several important factors including strategic developments, government regulations, market analysis, and the profiles of end users and target audiences. Additionally, it examines the distribution network, branding strategies, product portfolios, market share, potential threats and barriers, growth drivers, and the latest industry trends.

Pharmaceutical Contract Research Organization Market Segmentation

The report on the Global Pharmaceutical Contract Research Organization Market offers a thorough segmentation by type, applications, and regions. It details production and manufacturing data for each segment over the forecast period from 2024 to 2032. The application segment focuses on the different uses and operational processes within the industry. Analyzing these segments will provide insights into the various factors contributing to market growth and their significance.

The report is segmented as follows:

Segment By Type

Active Pharmaceutical Ingredient

Finished Dosage Formulation

Segment By Application

Pharmaceutical and Biopharmaceutical Companies

Medical Device Companies

Academic Institutes

Pharmaceutical Contract Research Organization Market Segmentation by Region

North America

U.S

Canada

Europe

Germany

UK

France

Asia Pacific

China

India

Japan

Australia

South Korea

Latin America

Brazil

Middle East & Africa

UAE

Kingdom of Saudi Arabia

South Africa

Get Detailed Segmentation @ https://reedintelligence.com/market-analysis/global-pharmaceutical-contract-research-organization-market/segmentation

The market research report on the Global Pharmaceutical Contract Research Organization Market has been thoughtfully compiled by examining a range of factors that influence its growth, including environmental, economic, social, technological, and political conditions across different regions. A detailed analysis of data related to revenue, production, and manufacturers provides a comprehensive view of the global landscape of the Pharmaceutical Contract Research Organization Market. This information will be valuable for both established companies and newcomers, helping them assess the investment opportunities in this growing market.

Key Highlights

The report delivers essential insights into the Global Pharmaceutical Contract Research Organization Market.

The report covers data for the years 2024-2032, highlighting key factors that impact the market during this period.

It emphasizes technological advancements, government regulations, and recent market developments.

The report will explore advertising and marketing strategies, examine market trends, and provide detailed analysis.

The report includes growth analysis and forecasts, with predictions extending up to the year 2032.

The report highlights a detailed statistical analysis of the key players in the market.

It presents a comprehensive and extensively researched overview of the market.

Buy Pharmaceutical Contract Research Organization Market Research Report @ https://reedintelligence.com/market-analysis/global-pharmaceutical-contract-research-organization-market/buy-now

Contact Us:

Email: sales@reedintelligence.com

[mordorintelligencemarketresearch]

The Pharmaceutical Glass Vials and Ampoules Market: Insights and Future Trends 

Introduction 

The pharmaceutical glass vials and ampoules market plays a crucial role in the global healthcare landscape. These glass containers are essential for storing and preserving medications, vaccines, and other biologics, ensuring their integrity and effectiveness. As the pharmaceutical industry continues to expand, understanding the dynamics of this market is vital for stakeholders. 

Market Overview 

Current Market Size and Growth 

The Pharmaceutical Glass Vials and Ampoules market is projected to be valued at approximately USD 14.82 billion in 2024 and is expected to grow to around USD 20.73 billion by 2029. This growth reflects a compound annual growth rate (CAGR) of 6.94% during the forecast period from 2024 to 2029. This growth is largely driven by an increase in drug production and the rising demand for biologics and sterile products. 

Key Drivers of Growth 

Rising Biologics Demand: The increasing prevalence of chronic diseases and the growing biologics sector are major factors driving the demand for glass vials and ampoules. These products are preferred for their ability to maintain the stability and efficacy of sensitive formulations. 

Safety and Stability: Glass is inherently inert and non-reactive, making it an ideal material for pharmaceutical applications. Its ability to preserve the integrity of the contents, especially in sterile environments, boosts its popularity. 

Growing Vaccine Production: The COVID-19 pandemic has led to a surge in vaccine development and production, significantly impacting the demand for glass containers like vials and ampoules. 

Increasing Investment in R&D: Pharmaceutical companies are investing heavily in research and development, leading to the production of more complex and sensitive drugs that require specialized packaging solutions. 

Regional Insights 

North America 

North America is a leading market for pharmaceutical glass vials and ampoules, driven by a well-established pharmaceutical industry and stringent regulatory standards. The region's focus on innovation and quality assurance bolsters the demand for high-performance glass containers. 

Europe 

Europe also holds a significant share of the market, with countries like Germany and France leading in pharmaceutical production. The rising focus on biologics and biosimilars is further propelling market growth in this region. 

Asia-Pacific 

The Asia-Pacific region is expected to experience the highest growth rate, fueled by rapid industrialization, increasing healthcare expenditures, and a growing population. Emerging markets such as China and India are becoming key players in pharmaceutical manufacturing, driving the demand for glass vials and ampoules. 

Challenges Facing the Industry 

While the pharmaceutical glass vials and ampoules market is expanding, several challenges must be addressed: 

Cost of Production: The high cost of glass manufacturing can limit profitability, especially for smaller companies in a price-sensitive market. 

Regulatory Compliance: Adhering to stringent regulations regarding quality and safety can be complex and resource-intensive for manufacturers. 

Competition from Alternative Materials: The rise of alternative packaging materials, such as plastics and polymers, poses a potential threat to the glass market. 

Future Outlook 

The pharmaceutical glass vials and ampoules market is poised for continued growth, driven by several key trends: 

Sustainability Initiatives: As the industry moves toward sustainable practices, manufacturers are exploring eco-friendly production methods and recyclable glass solutions. 

Technological Advancements: Innovations in glass production, including improvements in design and functionality, will enhance the performance of vials and ampoules, catering to evolving market needs. 

Expansion in Emerging Markets: Increased investment in healthcare infrastructure in developing regions will create new opportunities for growth in the pharmaceutical glass packaging sector. 

Conclusion 

The pharmaceutical glass vials and ampoules market is on an upward trajectory, driven by rising demand for biologics, stringent safety standards, and ongoing innovations in packaging solutions. Stakeholders who focus on quality, sustainability, and technological advancements will be well-positioned to capitalize on the opportunities that lie ahead in this essential industry.    For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/pharmaceutical-glass-vials-and-ampoules-market 

[mordormr]

Shaping the Future: Growth Prospects in Australia’s Pharmaceuticals Market

The Australia pharmaceuticals market is projected to be valued at USD 13.21 billion in 2024 and is anticipated to reach USD 17.89 billion by 2029, registering a compound annual growth rate (CAGR) of 6.25% during the forecast period from 2024 to 2029. The market is set for continued growth, driven by advancements in healthcare, an aging population, and a robust regulatory environment. Based on insights from Mordor Intelligence, here’s an overview of the key factors shaping the future of the industry:

Market Overview: Key Growth Drivers

Aging Population and Chronic Disease Management: Australia's aging population is a significant factor contributing to the growth of the pharmaceuticals market. With increasing cases of chronic diseases such as diabetes, cardiovascular disorders, and cancer, the demand for prescription drugs and specialty treatments is on the rise.

Government Healthcare Initiatives: Government support through policies like the Pharmaceutical Benefits Scheme (PBS) helps in subsidizing medicines, making them more accessible to the population. This not only boosts pharmaceutical sales but also encourages pharmaceutical companies to invest in new drug development.

Growth in Biopharmaceuticals: There is a growing focus on biopharmaceuticals, especially in the areas of oncology, immunology, and rare diseases. The development of biologics and biosimilars is expected to further fuel market growth, as these therapies offer new treatment options for complex medical conditions.

Innovations and Trends Shaping the Market

Personalized Medicine: The rise of precision medicine is one of the key trends in Australia’s pharmaceutical landscape. Personalized treatments, which are tailored to individual genetic profiles, are gaining popularity in areas such as oncology and immunology. This trend is driving innovation and investments in genetic research and drug development.

Digital Transformation: The integration of digital health technologies, including telemedicine and electronic health records, is transforming the pharmaceutical industry. These advancements enable better patient outcomes and streamline drug delivery processes, leading to improved healthcare services.

Growth of Generic Pharmaceuticals: As patents on several high-profile drugs expire, the market for generic pharmaceuticals is expanding. Generic drugs provide cost-effective alternatives to branded medicines, contributing to broader market accessibility.

Australia Pharmaceuticals Market Future Outlook

The Australia pharmaceuticals market is expected to see steady growth in the coming years, with increasing demand for advanced therapies and personalized medicine. Innovations in biotechnology and genomics will continue to play a pivotal role in the industry’s expansion, while government support will ensure access to essential medicines.

The market is projected to benefit from continued investments in R&D, particularly in biopharmaceuticals and rare disease treatments. With a growing emphasis on sustainability and digitalization, the pharmaceutical landscape in Australia is set to evolve, offering new growth opportunities for industry players.

Conclusion

The future of Australia’s pharmaceuticals market looks promising, with a strong focus on innovation, patient-centered care, and accessibility. Despite facing challenges such as regulatory barriers and high costs, the market is well-positioned for growth, driven by technological advancements and increasing healthcare demands.

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/australia-pharmaceutical-market

[colinwilson11]

Pharmaceutical Caps And Closures Market Will Grow At Highest Pace Owing To High Adoption Of Safety And Tamper Evidence Features

The pharmaceutical caps and closures market caters to the capsule-filling needs of pharmaceutical companies for packing prescribed drugs. Capsules made from gelatin help improve bioavailability and protect the drug from moisture, which enhances shelf life. Closures such as screw caps offer tamper evidence and ensure safety. The demand for such caps and closures is rising globally due to an aging population and growing prevalence of lifestyle diseases.

The Pharmaceutical Caps And Closures Market is estimated to be valued at US$ 6.4 Bn in 2024and is expected to exhibit a CAGR of 6.7% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the pharmaceutical caps and closures market are Aptar Pharma (AptarGroup), West Pharmaceutical Services, Datwyler Sealing Solutions (Datwyler Group), Lonstroff (Sumitomo Rubber Industries), and Ompi (Stevanato Group). Aptar Pharma and West Pharmaceutical Services collectively account for over 30% of the global market share.

The rising incidence of chronic diseases and increasing generic drug production are fueling demand for pharmaceutical capsules and closures globally. As per estimates, chronic diseases affect over 100 million people in the United States. This is prompting pharmaceutical companies to ramp up production.

Technological advancements are aiding capsule delivery systems. New gelatin compositions improve solubility and bioavailability, while innovative container closure combinations offer better tamper evidence. 3D printing technology is also being explored for high-quality capsule manufacturing.

Market Trends

Sustainability initiatives - Major market players are investing in eco-friendly closure and packaging solutions made from recycled PET and plant-based polymers to reduce plastic waste.

Digitalization - Pharma companies are digitizing packaging lines with track-and-trace solutions and integrating IoT sensors for automated inspection and quality control. This improves production efficiency.

Market Opportunities

Growth in emerging markets - With rising income levels, countries like India, Brazil and China offer lucrative opportunities for pharmaceutical supplies including caps and closures.

Personalized medicines - Tailored drugs require specialized delivery via advanced capsules, thus presenting attractive opportunities, especially in the orphan drug segment.

Impact Of COVID-19 On Pharmaceutical Caps And Closures Market

COVID-19 pandemic has disrupted all markets across the globe. The Pharmaceutical Caps And Closures market was also impacted severely due to disruptions in supply chain, trade restrictions, and lockdowns imposed by various governments. During the initial lockdown phase, production and operations were halted entirely. With restricted movement of goods, shortage of raw materials occurred which hampered manufacturing. Demand also dropped significantly from pharma companies as elective procedures and non-emergency treatments were postponed.

However, as the pandemic intensified, demand from pharmaceutical sector increased manifold for drugs, vaccines and medical supplies. Manufacturers ramped up production and worked on establishing alternative supply routes to meet the growing needs. Governments also took initiatives to support pharma industry and streamline approval processes. With vaccination drives currently underway worldwide, production of caps and closures is expected to remain high. Companies are making investments in expanding capacities and digitizing operations to ensure resilience against future crises. While short term impact was negative, COVID-19 has fast tracked industry’s overall growth trajectory in long run due to emphasis on health security.

In terms of geographical regions, North America region accounts for the largest share in Pharmaceutical Caps And Closures market in value terms currently. This is attributed to presence of major pharma companies, high healthcare spending and rapid adoption of new technologies. Asia Pacific region is expected to witness fastest growth during forecast period with rising incomes, healthcare reforms and increasing generic drug manufacturing in countries like India and China which will drive demand. Europe holds second largest regional market due to advanced pharmaceutical industry and strict quality and safety norms for packaging.

The United States accounts for majority value share within North American region for Pharmaceutical Caps And Closures market. This is because US is the largest pharmaceutical market globally and spends heavily on prescription drugs and medications. India from Asia Pacific region is poised to emerge as the fastest growing country level market during forecast period 2024-2031 backed by low cost manufacturing, government initiatives for domestic industry and changing disease patterns.

Get more insights on this topic: https://www.trendingwebwire.com/pharmaceutical-caps-and-closures-market-is-estimated-to-witness-high-growth-owing-to-innovations-in-tamper-evidence-solutions/

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

What Are The Key Data Covered In This Pharmaceutical Caps And Closures Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Pharmaceutical Caps And Closures's growth between 2024 and 2031.

:- Accurate calculation of the size of the Pharmaceutical Caps And Closures and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Pharmaceutical Caps And Closures Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Pharmaceutical Caps And Closures vendors

FAQ’s

Q.1 What are the main factors influencing the Pharmaceutical Caps And Closures?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Pharmaceutical Caps And Closures companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Pharmaceutical Caps And Closures’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

[chemxpert]

The Challenges and Opportunities of Chemical Data Collection

Chemical data gathering is widely used in the current research and industries as an important and fundamental step. Ranging from protection of human life in manufacturing industries to promoting research on pharmaceuticals chemical data  is the key building block in so many uses. Looking at the future and considering the fact that mankind is getting deeper into the digital era, it is crucial to look at the trends in chemical data collection today as there are both opportunities and threats. This blog covers the current status and the potential trends that seem likely to develop in the world of attaining chemical data.

[marketsndata]

[poonamcmi]

Pharmaceutical Analytical Testing Market Is Estimated to Witness High Growth Owing to Increasing Emphasis on Test

Pharmaceutical analytical testing involves various activities such as testing of raw materials, packaging components, in-process testing as well as final product testing to ensure quality and safety standards. It helps in determining product identity, strength, quality and purity as well as identifying potential contaminants. Some common analytical testing methods used in pharmaceutical industry include chromatography, spectroscopy, titrimetry and physical tests. It plays a vital role in drug development and production by testing drug substances, excipients as well as final drug products. Increasing regulatory mandates pertaining to safety and efficacy of drugs have further accelerated the need for analytical testing in pharmaceutical industry.

The global pharmaceutical analytical testing market is estimated to be valued at US$ 8.41 Bn in 2024 and is expected to exhibit a CAGR of 8.7% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the pharmaceutical analytical testing are Alibaba Group Holding Limited, Redcentric Plc., Amazon Web Services, Inc., Rackspace Hosting, Inc., Dell EMC, Oracle Corporation, Google LLC, Microsoft Corporation, Hewlett Packard Enterprise Development LP, and International Business Machines Corporation. These major players are focusing on strengthening their presence through mergers and acquisitions as well as launching new testing technologies to enhance their market share.

The Pharmaceutical Analytical Testing Market Size include increasing scope of outsourcing testing activities, growing demand for specialized analytical testing from biopharmaceutical companies and uptake of automated analytical systems. Testing services providers are targeting these opportunities by expanding their geographical presence as well as service portfolio.

Globally, North America dominates the pharmaceutical analytical testing market due to stringent regulatory environment. However, Asia Pacific is expected to witness highest growth owing to increasing investments by international test providers as well as surge in domestic pharmaceutical manufacturing activities. Countries like China and India offer huge potential for outsourced pharmaceutical analytical testing.

Market Drivers Increasing emphasis on test efficiency and quality is a major growth driver for pharmaceutical analytical testing market. Rising need to lower testing costs amid price control regulations has prompted companies to adopt advanced automated analytical techniques and high-throughput systems. Growing complexity of drug molecules also necessitates analytical characterization at each stage of drug development and manufacturing, driving the demand for analytical testing services globally.

PEST Analysis

Political: Pharmaceutical Analytical Testing Market Size And Trends  are regulated by agencies like the US FDA and the EU EMA. Any changes in regulations can impact the type and frequency of testing required.

Economic: Growth in the pharmaceutical industry and increasing drug development activities drive the need for analytical testing services. Changes in the economic conditions can impact R&D spending by pharma companies.

Social: Increase in lifestyle diseases and an aging population are driving the demand for new drugs. This leads to higher need for analytical testing during drug development and manufacturing.

Technological: Adoption of newer tools like artificial intelligence and automation are helping speed up testing processes and data analysis. Technologies like biologics also require specialized analytical characterization techniques.

The Asia Pacific region is one of the largest and fastest growing markets for pharmaceutical analytical testing in terms of value. The Asia Pacific pharmaceutical market has been growing at a high rate led by economies like China, India and South Korea. The presence of major generic drug manufacturers has supported the growth of analytical testing outsourcing in this region.

North America is currently one of the most concentrated markets for pharmaceutical analytical testing globally. It accounts for the highest revenue share due to the large pharmaceutical industry, stringent regulatory requirements as well as the focus on new drug development by major players in the US and Canada. The rising complexity of analytical techniques required also contributes to the high testing expenditures in the region. Get More Insights On, Pharmaceutical Analytical Testing Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191

[luckydige45]

According to latest report, the global active pharmaceutical ingredient CDMO market size was estimated at USD 119.80 billion in 2023 and is projected to hit around USD 249.22 billion by 2033, growing at a CAGR of 7.6% during the forecast period from 2024 to 2033. Asia Pacific had dominated in the market with the largest revenue share of 38.11% in 2023.

[industrynewsupdates]

Active Pharmaceutical Ingredients Market: Key Companies and Emerging Trends 2024-2030

The global active pharmaceutical ingredients market size was estimated at USD 237.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.75% from 2024 to 2030. 

Advancements in Active Pharmaceutical Ingredient (API) manufacturing, growth of the biopharmaceutical sector, and an increase in geriatric population are among the key drivers of API market. An increase in prevalence of chronic diseases, such as cardiovascular diseases and cancer, is anticipated to boost market growth.

Global geriatric population is increasing. According to UN, in 2022, people aged 65 and above accounted for 771 million of the population, and the number is anticipated to reach 994 million by 2030 to 1.6 billion by 2050. The number of elderly people is showing fastest growth in Africa, with a threefold increase estimated in people aged 60 and above, followed by Latin America, reaching 18.8 billion by 2050. Aging is considered the greatest risk factor for development of diseases, including cardiovascular and neurological diseases. Thus, rapidly growing global geriatric population is resulting to be a high-impact-rendering driver for API market.

Gather more insights about the market drivers, restrains and growth of the Active Pharmaceutical Ingredients Market

Increasing prevalence of infectious diseases and hospital-acquired infections is driving market growth. In addition, growing incidence of cardiovascular, genetic, and neurologic disorders is anticipated to act as a high-impact-rendering driver for market growth. Cardiovascular Diseases (CVDs) are the most prevalent causes of death globally. According to WHO, cardiovascular diseases cause death of 17.9 million people per day and are expected to cause approximately 25 million deaths by 2030. Increasing epidemiology of lifestyle, aided with rising number of smokers globally, growing incidence of obesity, and increasing dietary irregularities, are factors likely responsible to propel market growth. A recent report by the United Nations (UN) in May 2023 suggests that there has been a 75% increase in the number of girls and 61% in the number of boys with obesity in Europe.

Outsourcing of APIs has become profitable over in-house production. However, this trend took a different turn during the COVID-19 pandemic. Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer. In addition, risk mitigation is done using dual sourcing to ensure a continuous supply. Hence, key companies aim to capitalize on this ongoing outsourcing trend with new acquisitions. For instance, in August 2023, EUROAPI announced its deal to acquire BianoGMP to enhance its CDMO expertise in oligonucleotide manufacturing, which is a high-growth industry. This further demonstrates the company’s plans for vertical integration.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• The global antipsychotic drugs market size was valued at USD 16.88 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030. 

• The global drug and gene delivery devices market size was valued at USD 670.0 million in 2023 and is projected to grow at a CAGR of 9.0% from 2024 to 2030.

Active Pharmaceutical Ingredients Market Report Segmentation

Grand View Research has segmented the global active pharmaceutical ingredients market report based on type of synthesis, type of manufacturer, type, application, type of drug, and region:

Type of Synthesis Outlook (Revenue, USD Billion, 2018 - 2030)

• Biotech

o Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)

o Generic APIs

o Innovative APIs

o Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)

o Monoclonal Antibodies

o Hormones

o Cytokines

o Recombinant Proteins

o Therapeutic Enzymes

o Vaccines

o Blood Factors

• Synthetic

o Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)

o Generic APIs

o Innovative APIs

Type of Manufacturer Outlook (Revenue, USD Billion, 2018 - 2030)

• Captive APIs

• Merchant APIs

Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Generic APIs

• Innovative APIs

Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Cardiovascular Diseases

• Oncology

• CNS and Neurology

• Orthopedic

• Endocrinology

• Pulmonology

• Gastroenterology

• Nephrology

• Ophthalmology

• Others

Key Companies & Market Share Insights

Some of the leading players operating in the active pharmaceutical ingredients market include AbbVie, Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., and Eli Lilly and Company. Key players are using existing customer bases in the region to prioritize maintaining high-quality standards and gain high market size access. This marketing strategy is useful for brands that have already built trust in the market. These players are heavily investing in advanced technology and infrastructure, allowing them to efficiently process & analyze a large volume of samples. Moreover, companies undertake various strategic initiatives with other companies and distributors to strengthen their market presence.

Evonik, CARBOGEN AMCIS, and Pharmazell, are some of the emerging market participants in the ophthalmic drugs market. These companies focus on achieving funding support from government bodies and healthcare organizations aided with novel product launches to capitalize on untapped avenues. 

Key Active Pharmaceutical Ingredients Companies:

• Dr. Reddy’s Laboratories Ltd.

• Sun Pharmaceutical Industries Ltd.

• Teva Pharmaceutical Industries Ltd.

• Cipla Inc.

• AbbVie Inc.

• Aurobindo Pharma

• Sandoz International GmbH (Novartis AG)

• Viatris Inc.

• Fresenius Kabi AG

• STADA Arzneimittel AG

Recent Developments

• In August 2023, EUROAPI announced its deal to acquire BianoGMP to enhance its CDMO expertise in oligonucleotide manufacturing, which is a high-growth industry.

• In July 2023, Teva Pharmaceutical Industries Ltd. designed a new strategy for development with potential sale of its API unit on the table. The API manufacturing facility is worth USD 2 billion.

• In June 2023, Lonza acquired Synaffix to improve its ADC services portfolio.

• In April 2023, Eli Lilly announced an investment of USD 1.6 billion in the U.S.-based LEAP Innovation Park. This brings the total investment to USD 3.7 billion to manufacture complex APIs for products such as genetic medicine.

• In February 2023, Lonza completed the manufacturing of its facility in Switzerland. The company enhanced its capacity for its High Potent Active Pharmaceutical Ingredient (HPAPI) manufacturing facility.

• In January 2023, Sterling Pharma Solutions acquired an API manufacturing facility from Novartis in Ringaskiddy, Ireland.

Order a free sample PDF of the Active Pharmaceutical Ingredients Market Intelligence Study, published by Grand View Research. 

[mitalipingale]

https://twikkers.nl/blogs/250818/Veterinary-Active-Pharmaceutical-Ingredients-Manufacturing-Market-Share-Overview-Competitive-Analysis

The Veterinary Active Pharmaceutical Ingredients Manufacturing Market in 2023 is US$ 6.73 billion, and is expected to reach US$ 11.66 billion by 2031 at a CAGR of 7.10%.

[health-views-updates]

Active Pharmaceutical Ingredient Market: Future Opportunities and Challenges

Active Pharmaceutical Ingredient Market Outlook, Scope & Overview:

Industry reports indicate that the global active pharmaceutical ingredient (API) market was valued at USD 239.45 billion in 2023 and is projected to reach USD 371.06 billion by 2032, growing at a CAGR of 5.37% over the forecast period 2024-2032.

Technological Advancements to Drive Growth of Global Active Pharmaceutical Ingredient Market

The adoption of advanced manufacturing technologies and increasing investments in research and development will continue to influence global market revenues. Pharmaceutical companies are increasingly focusing on the development and production of high-quality APIs to meet the rising demand for effective and safe medications.

As a product segment, synthetic APIs currently hold a significant share of the global API market. This segment is anticipated to grow at a year-over-year rate of 5.37% in 2024 over 2023 and reach USD 371.06 billion in revenues by 2032. The increasing prevalence of chronic diseases, coupled with the growing need for innovative therapeutic drugs, is expected to drive market growth.

Active Pharmaceutical Ingredient Solutions – Market Dynamics

Drivers:

The API market is witnessing significant growth in the global market due to the rising demand for generic and branded drugs, the increasing prevalence of chronic diseases, and the growing emphasis on personalized medicine. Technological advancements in API manufacturing, such as the adoption of continuous manufacturing processes and green chemistry, are also key factors driving the adoption of APIs worldwide. Additionally, favorable government regulations and policies supporting pharmaceutical manufacturing are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as stringent regulatory requirements, high manufacturing costs, and the complexity of API production processes are hindering the widespread adoption of APIs. Moreover, the need for substantial investments in research and development, as well as the potential for supply chain disruptions, pose additional challenges to market expansion.

Active Pharmaceutical Ingredient Solutions – Market Outlook

The proven benefits of APIs in drug development, efficacy, and safety have contributed to the market's growth. APIs are expected to witness increased adoption across major pharmaceutical markets, including North America, Europe, and Asia Pacific, driven by advancements in manufacturing technologies and the growing demand for innovative and cost-effective medications.

Global Active Pharmaceutical Ingredient Market

The rise in demand for APIs in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global API market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of APIs, supported by favorable regulatory frameworks and increasing investments in pharmaceutical research and development.

Key Players in the Active Pharmaceutical Ingredient Solutions Market

Leading companies in the active pharmaceutical ingredient solutions market include Pfizer, Inc., Novartis International AG, Sanofi, and Teva Pharmaceutical Industries Ltd. These companies are at the forefront of developing and commercializing advanced API technologies for various therapeutic applications, including oncology, cardiovascular diseases, and infectious diseases.

In conclusion, the global active pharmaceutical ingredient market is poised for substantial growth over the forecast period, driven by technological advancements, increasing demand for effective medications, and the expanding adoption of innovative manufacturing processes across diverse pharmaceutical settings.

Other Trending Reports

AI in Pathology Market Share by Company

Healthcare Education Market Share by Company

Wearable Medical Devices Market Share by Company

Medical Foam Market Share by Company

[marketreports-blog]

According to latest report, the U.S. pharmaceutical market size was USD 602.19 billion in 2023, calculated at USD 639.22 billion in 2024 and is expected to reach around USD 1,093.79 billion by 2033, expanding at a CAGR of 6.15% from 2024 to 2033.

[soumyafwr]

Pharmaceutical Filtration Market Analysis, Size, Share, and Forecast 2031